135 related articles for article (PubMed ID: 34032998)
1. Polypharmacy and medication use by cancer history in a nationally representative group of adults in the USA, 2003-2014.
Hsu CD; Nichols HB; Lund JL
J Cancer Surviv; 2022 Jun; 16(3):659-666. PubMed ID: 34032998
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacy and prescription medication use in a population-based sample of adolescent and young adult cancer survivors.
Betts AC; Murphy CC; Shay LA; Balasubramanian BA; Markham C; Allicock M
J Cancer Surviv; 2023 Aug; 17(4):1149-1160. PubMed ID: 34997910
[TBL] [Abstract][Full Text] [Related]
3. Polypharmacy and patterns of prescription medication use among cancer survivors.
Murphy CC; Fullington HM; Alvarez CA; Betts AC; Lee SJC; Haggstrom DA; Halm EA
Cancer; 2018 Jul; 124(13):2850-2857. PubMed ID: 29645083
[TBL] [Abstract][Full Text] [Related]
4. Polypharmacy and medication fill nonadherence in a population-based sample of adolescent and young adult cancer survivors, 2008-2017.
Betts AC; Murphy CC; Shay LA; Balasubramanian BA; Markham C; Roth ME; Allicock M
J Cancer Surviv; 2023 Dec; 17(6):1688-1697. PubMed ID: 36346577
[TBL] [Abstract][Full Text] [Related]
5. Secular Trends in Central Nervous System-Active Polypharmacy Among Serial Cross-Sections of US Adults, 2009-2020.
Terman SW; Niznik JD; Growdon ME; Gerlach LB; Burke JF
Drugs Aging; 2023 Oct; 40(10):941-951. PubMed ID: 37695395
[TBL] [Abstract][Full Text] [Related]
6. Polypharmacy in patients with epilepsy: A nationally representative cross-sectional study.
Terman SW; Aubert CE; Hill CE; Maust DT; Betjemann JP; Boyd CM; Burke JF
Epilepsy Behav; 2020 Oct; 111():107261. PubMed ID: 32629416
[TBL] [Abstract][Full Text] [Related]
7. Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study.
Keats MR; Cui Y; DeClercq V; Grandy SA; Sweeney E; Dummer TJB
Support Care Cancer; 2021 Feb; 29(2):713-723. PubMed ID: 32444894
[TBL] [Abstract][Full Text] [Related]
8. Psychotropic polypharmacy and its association with health-related quality of life among cancer survivors in the USA: a population-level analysis.
Vyas A; Alghaith G; Hufstader-Gabriel M
Qual Life Res; 2020 Aug; 29(8):2029-2037. PubMed ID: 32207028
[TBL] [Abstract][Full Text] [Related]
9. Trends in Prescription Drug Use Among Adults in the United States From 1999-2012.
Kantor ED; Rehm CD; Haas JS; Chan AT; Giovannucci EL
JAMA; 2015 Nov; 314(17):1818-31. PubMed ID: 26529160
[TBL] [Abstract][Full Text] [Related]
10. Food insecurity among adult cancer survivors in the United States.
Trego ML; Baba ZM; DiSantis KI; Longacre ML
J Cancer Surviv; 2019 Aug; 13(4):641-652. PubMed ID: 31297721
[TBL] [Abstract][Full Text] [Related]
11. Comorbidities, Age, and Polypharmacy Limit the Use by US Older Adults with Nocturia of the Only FDA-approved Drugs for the Symptom.
Suvada K; Plantinga L; Vaughan CP; Markland AD; Mirk A; Burgio KL; Erni SM; Ali MK; Okosun I; Young H; Goode PS; Johnson TM
Clin Ther; 2020 Dec; 42(12):e259-e274. PubMed ID: 33257091
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH.
Moore HN; Mao L; Oramasionwu CU
AIDS Care; 2015; 27(12):1443-8. PubMed ID: 26608408
[TBL] [Abstract][Full Text] [Related]
13. Prescription medication use among patients with type 2 diabetes in the United States: 1999-2020.
Li S; Pan S; Jiang S; Shin JI; Liu GG; Lyu B
Diabetes Obes Metab; 2024 Jul; 26(7):2933-2944. PubMed ID: 38695210
[TBL] [Abstract][Full Text] [Related]
14. Association between polypharmacy and health-related quality of life among cancer survivors in the United States.
Babcock ZR; Kogut SJ; Vyas A
J Cancer Surviv; 2020 Feb; 14(1):89-99. PubMed ID: 31792811
[TBL] [Abstract][Full Text] [Related]
15. Use of Chronic Prescription Medications and Prevalence of Polypharmacy in Survivors of Childhood Cancer.
Ewig CLY; Cheng YM; Li HS; Wong JCL; Cho AHY; Poon FMH; Li CK; Cheung YT
Front Oncol; 2021; 11():642544. PubMed ID: 33869032
[TBL] [Abstract][Full Text] [Related]
16. Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective.
Sutaria A; Liu L; Ahmed Z
Ther Adv Cardiovasc Dis; 2016 Aug; 10(4):242-50. PubMed ID: 26920372
[TBL] [Abstract][Full Text] [Related]
17. Uses and perceptions of medications among French older adults: results from the 2020 French Health Barometer survey.
Tran AT; Soullier N; Ankri J; Herr M; Carcaillon-Bentata L
BMC Geriatr; 2022 Jul; 22(1):602. PubMed ID: 35858861
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study.
Loya AM; González-Stuart A; Rivera JO
Drugs Aging; 2009; 26(5):423-36. PubMed ID: 19552494
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and factors associated with polypharmacy in the older people: 2006-2014.
Carmona-Torres JM; Cobo-Cuenca AI; Recio-Andrade B; Laredo-Aguilera JA; Martins MM; Rodríguez-Borrego MA
J Clin Nurs; 2018 Aug; 27(15-16):2942-2952. PubMed ID: 29603814
[TBL] [Abstract][Full Text] [Related]
20. Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.
Hong S; Lee JH; Chun EK; Kim KI; Kim JW; Kim SH; Lee YG; Hwang IG; Kim JY; Koh SJ; Ko YH; Shin SH; Woo IS; Kim TY; Baek JY; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Ryoo HM; Kim JH
Oncologist; 2020 Mar; 25(3):e502-e511. PubMed ID: 32162799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
